11 April 2019

The transient receptor potential (TRP) channel superfamily is one of the largest classes of cation channels fulfilling an enormous diversity in physiological functions. In order to advance studies on the emerging number of TRP channel-related diseases and guide effective treatment, it is essential to have detailed molecular understanding of their structure and function. However, for the longest time, TRP channels resisted all attempts at detailed structural investigation.

In collaboration with the groups of Yifan Cheng and David Julius (UCSF, San Francisco, USA), Mark van Goor and Jenny van der Wijst, theme Renal disorders, employed cryo-electron microscopy (cryo-EM) to resolve atomic-level details of TRPV5, which are now published in Proceedings of the National Academy of Sciences.

The 2017 Nobel Prize-awarded cryo-EM technology allows scientists to obtain thousands of snapshots of frozen protein molecules. Following, these individual pictures can be reconstructed into movie-like scenes that are used to build the complete image of a molecular machinery such as TRPV5. TRPV5 serves as a gatekeeper for calcium transport across epithelial cell membranes in the kidney, and thereby plays an important role in maintaining the body’s calcium balance. The 3D structure of TRPV5 is solved in complex with a protein called calmodulin, which is essential to channel regulation. They demonstrate that calmodulin directly plugs the pore of the channel and disclosed the structural mechanism of TRPV5 channel inactivation. The team of Jenny van der Wijst follows up this fundamental line of work to answer long-standing questions about TRPV5’s (patho)physiological role in calcium homeostasis. Genetic variants of the TRPV5 gene are associated with calcium loss in the urine, and predispose people to the formation of kidney stones. Their high-resolution insight may pave the way for future studies towards targeted therapies to modulate channel function in people suffering from kidney stones and related disorders.

Related news items


Employees Personal Touch Jojanneke Huck

31 July 2020

In the monthly 'Employee's Personal Touch' an employee answers a few questions about the work, all with a personal touch. Now Jojanneke Huck tells us her story.

read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Testing medical mouth masks Developed in the Netherlands

30 July 2020

Auping and AFPRO developed medical mouth caps which were tested by Integrative Physiology. The results were shared with the producing companies.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more